Copenhagen, Denmark

Ebbe Ro Slashednne


Average Co-Inventor Count = 10.5

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ebbe Ro Slashednne: Innovator in Antibody Research

Introduction

Ebbe Ro Slashednne is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of antibody research, particularly in the development of monoclonal and polyclonal antibodies. With a total of 2 patents, his work focuses on innovative methods for detecting and utilizing urokinase plasminogen activator receptor (u-PAR).

Latest Patents

Ebbe Ro Slashednne's latest patents include groundbreaking advancements in antibodies and their applications. One of his key inventions involves a monoclonal or polyclonal antibody directed against u-PAR. This antibody can react with free u-PAR or with complexes between u-PA and u-PAR. It is capable of various functions, such as catching u-PAR in ELISA, detecting u-PAR in blotting, and precipitating purified u-PAR in intact or fragment form. Additionally, it is useful for immunohistochemical detection of u-PAR in cancer cells and inhibits the binding of pro-u-PA and active u-PA, thereby preventing cell surface plasminogen activation.

Career Highlights

Throughout his career, Ebbe Ro Slashednne has worked with prominent organizations, including Cancerforskningsfonden Af 1989 and Cancerforskningsfondet Af 1989. His research has led to the development of methods for detecting or quantifying u-PAR and for targeting diagnostics to cells containing u-PAR on their surface. He has also contributed to methods for preventing localized proteolytic activity in mammals and inhibiting cancer invasion and metastasis.

Collaborations

Ebbe Ro Slashednne has collaborated with notable colleagues, including Keld Dano Slashed and Niels Behrendt. Their combined expertise has further advanced the field of antibody research and its applications in cancer treatment.

Conclusion

Ebbe Ro Slashednne's innovative work in antibody research has the potential to significantly impact cancer diagnostics and treatment. His contributions to the understanding of u-PAR and its interactions are paving the way for new therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…